NEW YORK (TheStreet) -- CHANGE IN RATINGS
downgraded at Citigroup to Sell. Stock is now up 21% since announcing the BJS deal, doubling the performance of the industry. There are several integration risks in the deal.
Chicago Bridge & Iron
upgraded at Goldman from Neutral to Buy. Company has leverage to LNG in Australia and the relative valuation remains compelling.
upgraded at Credit Suisse to Outperform from Underperform based on upside in the engine aftermarket business and long term growth prospects. 2010 EPS estimate lifted to $1.60 from $1.55, 2011 maintained at $1.93. Price target surged to $41 from $28.
upgraded at Argus from Hold to Buy. $64 price target. Valuation call, to reflect improved operating performance and better earnings visibility.
downgraded at Goldman from Buy to Neutral. Stock lacks near-term catalysts and there's downside risk to third quarter earnings.
rated new Outperform at RBC Capital. Company has strong free cash flow and should benefit from tax credits, which will allow management to pay down debt. $27 price target.
upgraded at Fox-Pitt to Outperform. $55 price target. Estimates also raised.
estimates boosted at Goldman through 2011. Company is on track to deliver higher pre-provision earnings. Buy rating and $54 price target.
downgraded at Oppenheimer to Perform. $56 price target. Valuation call, as the company lacks near-term catalysts.
downgraded at Oppenheimer to Perform. $45 price target. $45 price target. Surprise death of CEO adds near-term risk to the thesis.
downgraded at Citigroup from Hold to Sell. Stock has little relative upside from current levels.
upgraded at Wells from Market Perform to Outperform. Company has an attractive mix of oil and natural gas. The stock also trades at a 26% discount to its peers.
upgraded at Citigroup from Hold to Buy. Market is under-estimating the company's earnings power. $27 price target.
upgraded at UBS from Neutral to Buy. $46 price target. Company's relative risk/reward is attractive at current levels.
upgraded at Barclays to Overweight from Equal Weight on significant upside potential. Price target surged to $30 from $18. 2009 and 2010 EPS estimates boosted to $2.19 from $1.81 and to $1.05 from $0.47, respectively.
downgraded at Merrill/BofA from Buy to Neutral. $23.50 price target. Wells notice for the YieldPlus fund, adds risk to the company's thesis.
upgraded at Citigroup from Hold to Buy. $80 price target. Estimates also boosted, to reflect an eventual rebound in drilling activity.
upgraded at Baird from Neutral to Outperform. $40 price target. Company's pricing appears to be holding up better than its peers.
downgraded at Stifel from Buy to Hold. Stock also removed from the Select List, as the market is already pricing in continued growth in the HDD market.
STOCK COMMENTS / EPS CHANGES
numbers boosted at Goldman through 2012. Company should see significant operating leverage from the Solvay deal. Buy rating and new $60 price target.
price target raised, estimates changed at Barclays. Price target to $23 from $20 on solid 3Q results. 2009 EPS trimmed to $1.16 from $1.19, 2010 raised to $1.31 from $1.27. Reiterate Equal Weight rating.
estimates, target boosted at Goldman. Shares of AN now seen reaching $17. Estimates also raised, to reflect lean inventory and higher margins. Sell rating.
Brookfield Asset Mgmt.
target increased at Credit Suisse to $24 from $20 on momentum and restructuring benefits. 2009 and 2010 EPS estimates set at $0.73 and $0.96, respectively. Reiterate neutral rating.
estimates lowered at Goldman through 2011. Company is spending more to deliver growth. Buy rating and $34 price target.
added to Top Picks list at Citigroup. Stock replaces CVC, as the company will likely gain and leverage full control of NBC Universal.
Crescent Point Energy
price target lifted at Weisel to $44 from $43 after the company announced a $575 million equity financing. Maintain Overweight rating.
numbers boosted at Morgan Stanley. Shares of DGI now seen reaching $31. Estimates also raised, to reflect the successful launch of a new satellite. Overweight rating.
estimates, target raised at Morgan Stanley. FAST estimates were increased through 2011. Company is seeing slightly better sales, but costs will also have to move higher. Underweight rating, based on premium valuation. New $31 price target.
numbers raised at FBR. Shares of GWW now seen reaching $116. Estimates also boosted, to reflect to reflect the company's operating momentum posted last quarter. Outperform rating.
price target higher at Credit Suisse to $24 from $21. 2009 and 2010 EPS estimates set at $0.13 and $0.22, respectively. Maintain Outperform rating.
price target boosted at Barclays to $55 from $46 following robust 3Q results. 2009 and 2010 EPS estimates increased to $2.15 from $1.80 and to $3.65 from $3.25, respectively. Maintain Overweight rating.
price target, estimates higher at Weisel. LLTC price target boosted to $33 from $30. 2010 and 2011 EPS estimates lifted to $1.28 from $1.07 and to $1.60 from $1.37, respectively. Maintain Overweight rating.
estimates raised at Goldman through 2010. Company continues to benefit from a recovery in industrial demand. Buy rating and $30 price target.
price target lifted at Credit Suisse to $45 from $44 after solid 3Q results. 2009 and 2010 EPS estimates set at $1.45 and $1.70, respectively. Reiterate Outperform rating.
estimates boosted at Goldman through 2012. Company will ultimately benefit from higher PC unit sales. Buy rating and $30 price target.
numbers boosted at Morgan Stanley. Shares of MSM now seen reaching $39. Estimates also raised, to reflect signs of more stable demand in the industrial sector. Underweight rating.
numbers raised at UBS. PM estimates were increased through 2010. Company should benefit from a weaker dollar. Neutral rating and new $49 price target.
numbers raised at Goldman. Estimates were increased through 2011. The company is positioned best to benefit from supply oost savings. Buy rating and new $8 price target.
price target raised at Merrill/BofA to $21.50 from $15 on valuation. 2009 and 2010 EPS estimates set at -$0.20 and $0.85, respectively. Maintain Neutral rating.
price target raised at Credit Suisse to $30 from $25. 2009 and 2010 EPS estimates increased to $2.12 from $2.04 and to $2.25 from $2.15, respectively. Maintain Neutral rating.
price target raised at Barclays to $26 from $25. 2010 EPS estimate increased to $1.05 from $0.94, 2011 introduced at $1.32. Reiterate Overweight rating.
This article was written by a staff member of TheStreet.com.